Table 3.
(A) Inhibition of cell proliferation using EGCG | |||
Nasopharyngeal cancer | TW01 sphere | TW01 parental | Lin et al. (2012) |
ID50 μM | 150 | 60 | |
TW06 sphere | TW06 parental | Lin et al. (2012) | |
ID50 μM | 115 | 38 | |
Neuroblastoma | BE(2)-C sphere | BE(2)-C parental | Nishimura et al. (2012) |
EGCG 50 μM | 25.2 (% of inhibition) | 93.8 (%) | |
(B) Induction of apoptosis using EGCG | |||
Nasopharyngeal cancer | TW01 sphere | TW01 parental | Lin et al. (2012) |
EGCG 40 μM | 12.7 (%) | 63.6 (%) | |
Neuroblastoma | BE(2)-C sphere | BE(2)-C parental | Nishimura et al. (2012) |
EGCG 50 μM | 9.1 (%) | 91.7 (%) |